Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

This study is ongoing, but not recruiting participants.

Study NCT00229697 Information provided by AstraZeneca

First Received: September 28, 2005 Last Updated: February 9, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)